Brant Clayton Boren

This inventor holds 13 USPTO granted patents and 13 published patent applications and 5 EPO patents. Top assignees: Recurium IP Holdings, LLC, Exelixis Patent Company LLC, Firmenich Incorporated. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brant Clayton Boren. Retrieved from https://idiyas.com/inventor/brant-clayton-boren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 13)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 19)

Average Co-Inventor Count = 8.4

ph-index = 4

Forward Citations = 44(Granted Patents)

Company Filing History:

6 out of 30

Recurium IP Holdings, LLC

patents

3 out of 13

Exelixis Patent Company LLC

patents

3 out of 24

Firmenich Incorporated

Years Active: 2011-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753178 - Methods of making WEE1 inhibitor compounds (2026-10-06),

2. 12714710 - Combinations (2026-08-25),

3. 12410204 - Chiral synthesis of a tertiary alcohol (2025-09-09),

4. 11339128 - Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers (2022-05-24),

5. 11261192 - Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones (2022-03-01),

6. 11242327 - Analgesic compounds (2022-02-08),

7. 11124518 - L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs (2021-09-21),

8. 11028052 - Compounds useful as modulators of TRPM8 (2021-06-08),

9. 10421727 - Compounds useful as modulators of TRPM8 (2019-09-24),

10. 9840471 - Compounds useful as modulators of TRPM8 (2017-12-12),

11. 8846739 - TGR5 agonists (2014-09-30),

12. 8785488 - Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity (2014-07-22),

13. 7998995 - LXR and FXR modulators (2011-08-16),

Dear client, based on the data provided, here is an article about the inventor Brant Clayton Boren:

Title: The Innovative Journey of Brant Clayton Boren

Introduction: In the vibrant city of San Diego, California, resides a prolific inventor by the name of Brant Clayton Boren. With an impressive portfolio of 10 patents, Boren has made significant contributions to the fields of flavor modulation and pharmaceuticals.

Latest Patents: Boren's recent patents showcase his versatility and ingenuity. One of his latest inventions involves Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids, which act as sweet flavor modifiers. Additionally, his work on Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones highlights their potential in treating diseases like breast cancer.

Career Highlights: Throughout his career, Brant Clayton Boren has been associated with esteemed companies such as Exelixis Patent Company LLC and Firmenich Incorporated. His innovative spirit and dedication to research have led to groundbreaking discoveries in the realm of patentable technologies.

Collaborations: Boren's success is also attributed to the collaborative efforts with professionals like Donald Karanewsky and Raju Mohan. These partnerships have fostered a culture of innovation, leading to the development of novel solutions with real-world applications.

Conclusion: In conclusion, Brant Clayton Boren stands as a testament to the power of innovation and persistence in the realm of patents and inventions. His pioneering work continues to shape industries and impact lives, solidifying his legacy as a visionary inventor.

Profile summary based on public USPTO records.